Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor, Adult × niraparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 60 Breast Neoplasms 18 Prostatic Neoplasms 14 Neoplasms 14 Fallopian Tube Neoplasms 14 Neoplasm Metastasis 8 Pancreatic Neoplasms 7 Glioblastoma 7 Endometrial Neoplasms 6 Triple Negative Breast Neoplasms 5 Lung Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Glioma 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Mesothelioma 3 Melanoma 3 Head and Neck Neoplasms 3 Cholangiocarcinoma 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Sarcoma 2 Prostatic Neoplasms, Castration-Resistant 2 Mesothelioma, Malignant 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2

Interventions

olaparib 1 niraparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04972110 2025-10-30

ATTACC

Repare Therapeutics

Phase 1/2 Terminated

156 enrolled 19 charts

Other solid neoplasm

Advanced Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡